News

  • Professor Alan Trounson

    Lifesaving ‘off-the-shelf’ cancer tracking immunotherapies underway

    ‘Off-the-shelf’ immunotherapies to fight aggressive forms of cancer, including relapsed ovarian and gastric cancers, are being developed in Clayton, Melbourne, thanks to almost $3 million in Federal Government funding awarded to lead participant Cartherics Pty Ltd. Hudson Institute of Medical Research and Monash University researchers are partnering with industry leaders in cell therapies to develop…  Read more

  • Courtney McDonald

    2018 Harold Mitchell Foundation Travel Fellowships

    Congratulations to the 2018 recipients of The Harold Mitchell Foundation Travel Fellowships. These fellowships are equipping our young scientists with the experience, cutting-edge knowledge and professional links that will let them make a major difference to medical science both in Australia and throughout the world. The Harold Mitchell Foundation Fellowships enable a promising young Hudson…  Read more

  • Dr Shayanti Mukherjee from the Endometrial Stem Cell Biology Research Group at Hudson Institute

    2018 Hudson Institute Travel and Equity Awards

    Congratulations to the 2018 Hudson Institute Travel Awards recipients, who will attend international conferences and visiting laboratories to build invaluable knowledge in their area of research. The Awards (supported by donations from the Grisha Sklovsky Memorial Fund and Philip Wind Travel Fund) support six Hudson Institute Postdoctoral Fellows and PhD students to gain experience relevant…  Read more

  • 2018 Hudson Institute Equity Awards

    The Hudson Institute Equity Travel Awards assists a staff member who has a career disruption to progress their research and career development. Dr Genevieve PepinCentre for Innate Immunity and Infectious DiseasesResearch Group: Nucleic Acids and Innate ImmunitySupervisor: Dr Michael Gantier The award will enable Genevieve to present her data at the International Cytokines and Interferon…  Read more

  • Discovery of bladder ‘mini-microbiome’ signals UTI treatment change

    Cutting edge genomics has now shown the female bladder is home to a community of bacteria – similar to the gut microbiome – even in the absence of infection. The research could provide new urinary tract infection (UTI) treatments.…  Read more

  • 2018 Centre for Reproductive Health Travel Awards

    Through the generosity of an anonymous donor, the Centre for Reproductive Health (CRH) is able to provide a highly competitive travel award of $2,500 to each of one CRH post-doctoral fellow and one CRH PhD student.  This offers a wonderful opportunity for our future research leaders to showcase their accomplishments. 2018 CRH Travel Award recipients…  Read more

  • Professor Rosemary Horne, Research group head for Infant and Child Health at Hudson Institute

    Poor sleep in children with cystic fibrosis linked to poor mood, depression

    A new study has shown that children and adolescents with cystic fibrosis (CF) experience poor sleep that may impact their mood and quality of life, and this could even be associated with depression. The study, led by Professor Rosemary Horne’s team at Hudson Institute of Medical Research in collaboration with Monash University and the Royal…  Read more

  • A Melbourne innovation is rapidly changing the way cell therapies are manufactured to treat diseases including stroke & cerebral palsy.

    Melbourne innovation set to revolutionise cell therapy industry

    A world-leading Melbourne innovation is rapidly changing the way cell therapies are manufactured to treat diseases including stroke and cerebral palsy, taking these treatments out of the lab and into hospitals. The new cell-processing technology, ROTEA, developed by Melbourne start-up, Scinogy in conjunction with Hudson Institute of Medical Research, is significantly reducing the costs and…  Read more

  • New role for cell death-related protein in stomach cancer

    New research from Hudson Institute of Medical Research is showing how a pro-inflammatory protein could offer new hope for stomach cancer treatment. A study, led by Dr Virginie Deswaerte and Professor Brendan Jenkins, found that modifying key components of the inflammatory response in the body could help to prevent tumour growth. The findings have been…  Read more

  • Tuberculosis study reveals new target to improve treatment and survival

    A new study into tuberculosis has revealed a novel target – hidden in a gene – that could reduce susceptibility to one of the world’s most deadly diseases. The study involved scientists at Hudson Institute of Medical Research and was led by Centenary Institute scientists, Dr Warwick Britton and Dr Carl Feng at the University…  Read more

Hudson News

Get the inside view on discoveries and patient stories

Stay connected